Short answer
Intuitive Surgical (ISRG) filed an 8-K current report with the SEC on July 16, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results covered quarter ended June 30, 2026.
Intuitive Surgical 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results covered quarter ended June 30, 2026
- Press release issued July 16, 2026, with financial results in Exhibit 99.1
- Exhibit furnished under Item 2.02, limiting Section 18 Exchange Act liability
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $2.89B, up 19%, with instruments/accessories reaching $1.73B on 15% da Vinci procedure growth
- Da Vinci placements rose to 468 from 395, including 246 da Vinci 5 systems, strengthening future recurring consumables revenue
- Installed base expanded to 11,710 da Vinci systems and 1,096 Ion systems, supporting long-term utilization growth
- GAAP EPS $2.29 versus $1.81; results included an $0.08 tariff-refund benefit, limiting comparability
- 2026 outlook targets 13.5%-15.5% da Vinci procedure growth and 68.0%-69.0% non-GAAP gross margin, with tariffs estimated at 1.0% of revenue
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Intuitive Surgical 8-K filings
Get the next ISRG 8-K as it lands
Follow ISRG for push alerts, or ask the research agent what this filing means.